Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
Paschalis Evangelidis, Medical Doctor, Former Teaching Assistant at Aristotle University of Thessaloniki (AUTH), shared a post on LinkedIn about a recent article he and Eleni Gavriilaki co-authored, published in Blood Advances, adding:
“Pleased to share our recent Letter to the Editor, published in Blood Advances, together with Eleni Gavriilaki.
In response to the recent study by Nagao et al., we highlight the multifactorial nature of cardiovascular risk in people with hemophilia, with particular emphasis on hypertension and its potential links to chronic inflammation, endothelial dysfunction, and vascular remodeling.
Moreover, we emphasize the importance of multidisciplinary collaboration among hematologists, cardiologists, hypertension specialists, and nephrologists to improve cardiovascular risk assessment and management in this population.”
Title: Cardiovascular risk and endothelial injury in hemophilia
Authors: Paschalis Evangelidis, Eleni Gavriilaki
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks